Author

Anthony Xu

Observed name: A T Xu

Institution: Baylor College of Medicine

Observed institution: Baylor College of Medicine

OpenAlex ID: A5135098460

Real-World Effectiveness of Upadacitinib for Perianal Crohn’s Disease: A Multicenter Retrospective Study

2026 · Jalpa Devi, Anish Patel, et al. · Clinical Gastroenterology and Hepatology · 3

Su1677 BASELINE PREDICTORS AND CLINICAL OUTCOMES OF RISANKIZUMAB DOSE OPTIMIZATION: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY

2026 · Amanda M. Johnson, Prajith R. Ramesh, et al. · Gastroenterology

Tu1652 REAL WORLD DURABILITY OF RESPONSE AND REMISSION AND PREDICTIORS AND OUTCOMES OF DOSE RE-ESCALATION OF UPADACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER STUDY

2026 · Katherine Huang, Arun Chandnani, et al. · Gastrointestinal Endoscopy

Tu1652 REAL WORLD DURABILITY OF RESPONSE AND REMISSION AND PREDICTIORS AND OUTCOMES OF DOSE RE-ESCALATION OF UPADACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER STUDY

2026 · Katherine Huang, Arun Chandnani, et al. · Gastroenterology

Su1677 BASELINE PREDICTORS AND CLINICAL OUTCOMES OF RISANKIZUMAB DOSE OPTIMIZATION: A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY

2026 · Amanda M. Johnson, Prajith R. Ramesh, et al. · Gastrointestinal Endoscopy

P0577 real world durability of response and remission with upadacitinib in Ulcerative Colitis: a multi-centre study

2026 · K Huang, A Chandnani, et al. · Journal of Crohn s and Colitis

Works count: 6

Citation count: 3

H-index: 1

I10-index: